Hypertension in renal parenchymal disease: why is it so resistant to treatment? (Q36417735)

14 August 2017

1 reference

title

Hypertension in renal parenchymal disease: why is it so resistant to treatment? (English)

1 reference

14 August 2017

main subject

arterial hypertension

0 references

author name string

Campese VM

series ordinal

1

1 reference

14 August 2017

Mitra N

series ordinal

2

1 reference

14 August 2017

Sandee D

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

69

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

967-973

1 reference

Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Sympathetic overactivity in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in the cat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Baroreflex sensitivity in patients on long-term haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Influence of ultrafiltration on plasma renin activity and adrenergic system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

The endothelin system and its potential as a therapeutic target in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Endothelin-induced modulation of neuropeptide Y and norepinephrine release from the rat mesenteric bed.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Antioxidants block angiotensin II-induced increases in blood pressure and endothelin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Evidence for endothelin involvement in the response to high salt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Salt-sensitive hypertension in endothelin-B receptor-deficient rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Increased plasma endothelin level in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Plasma endothelin in human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Plasma endothelin levels in patients with uraemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Endothelin-3 concentrations in human plasma: the increased concentrations in patients undergoing haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Abnormalities of endothelial function in patients with predialysis renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Impact of aortic stiffness on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Impaired endothelial function in isolated human uremic resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Effect of 2,3-dimercaptosuccinic acid on nephrosclerosis in the Dahl rat. I. Role of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Hydrogen peroxide induces intracellular calcium oscillations in human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Mechanism of erythropoietin-induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000177

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000177

1 reference

14 August 2017

1 reference